Vafseo (vadadustat)

Manufacturer:

Akebia Therapeutics

Route of Administration:

Oral

Site of Care:

Outpatient

Website:

Manufacturer Website

phone:

Enrollment Forms:

Synergen Prescription Form

Patient Support Form

Approved Indication:

treatment of anemia due to chronic kidney disease in adults who have been receiving dialysis for at least three months

Conditions:

Anemia
Chronic Kidney Disease

Therapeutic Area:

Nephrology